Chung-Guei Huang

Title: Innovations of Chung-Guei Huang in Immunology

Introduction

Chung-Guei Huang is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of immunology, particularly in the context of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). His innovative methods have the potential to enhance our understanding of immune responses to this virus.

Latest Patents

Chung-Guei Huang holds a patent for a method for determining immune competence against SARS-CoV-2. This method involves obtaining a blood sample from a subject, detecting levels of binding antibodies against the SARS-CoV-2 spike S1 protein and its receptor binding domain (RBD), and calculating a weighted value using a regression model. This innovative approach provides valuable insights into the immune response to the virus.

Career Highlights

Throughout his career, Chung-Guei Huang has been associated with prestigious institutions such as Chang Gung University and Chang Gung Memorial Hospital in Linkou. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to important research initiatives.

Collaborations

Chung-Guei Huang has worked alongside Kuan-Ting Liu, further enhancing the collaborative efforts in his research endeavors.

Conclusion

Chung-Guei Huang's contributions to immunology, particularly through his patent on determining immune competence against SARS-CoV-2, highlight his role as an innovative inventor. His work continues to impact the field and offers promising avenues for future research.